David Wang
Analyst · Needham & Company. Please ask your question
Thanks, Gary, and welcome, everyone, to today's call. I hope that each of you and your families are staying safe and healthy in light of the COVID situation. Our heart go out to those who have been personally impacted by the pandemic. I also want to thank all the healthcare workers around the world who are fighting the virus on the frontline and saving lives. To support the effort in February, we donated 30,000 marks and 300 full cover hazarded suits to Wuhan. More recent, we donate 10,000 masks to New York and California. Despite the virus impact, we had a busy and productive first quarter. Our first priority was the safety of our employees. After that, we focus on making progress in growth for the year. We achieved customer acceptances. For demo tools, introduced new products and delivered solid financial results. We are moving forward with key strategic actions that support our mission to become a major supplier of capital equipment to the semiconductor industry. Now some highlights for the quarter on Slide 3. We are pleased with our financial results. We delivered $24.3 million in sales, up 19% year on year. Shipments were $12 million. We delivered double-digit revenue growth, even though some shipments delayed from Q1 into Q2. Spending was up as expected. We invested and focus R&D to support new product introduction. We increased sales and marketing to penetrate new customers, and we had higher G&A to prepare for our STAR Market IPO. We ended the quarter with a solid balance sheet with $52 million of cash and another $59 million in restricted cash from last year's private equity withdrawal. Please turn to Slide 4. During the quarter, we achieved a major milestone with our Tahoe product. On last quarter's call, we reported positive results for Tahoe in a production environment as a lead customer. I'm now excited to report that Tahoe achieved first two acceptance at that customer. Resulting revenue recognition in Q1. This represents a great achievement for ACM and for the industry. Tahoe is a unique platform compared to other single-wafer SPM cleaning tool. Tahoe offers the same or even better performance while using only a fraction of the sulfuric acid. Sulfuric acid is environmental problem for the entire industry. Our tool is one of our 10 solution that delivers good performance, benefits the environment, and reduces operational costs with significantly less chemical use. Even more exciting today, we report that we received repeat order from Tahoe from this lead customer. We plan to deliver tool for revenue in the coming quarters. The environmental advantages of Tahoe put us in a great position to engage with new potential customers in Taiwan, North America, and Europe. We expect more momentum from Tahoe including orders for additional demo tools as the year progresses. Our customers are happy with our current products and are pushing us to provide more tools for cleaning and for other manufacturer steppers. In response to the demand, I have a few exciting new products to share with you today. Please turn to Slide 5. Yesterday, we introduced a latest addition to ACM cleaning product line, three new semi-critical wet cleaning tools for front and backside wafer process. The new tools are first, the Ultra C b for the back side cleaning; next, Ultra C wb for automated wet bench; and the third, Ultra C s for scrubber. These new tools, expanding our opportunity to even more clean steps at our major customers and we estimate to add approximately $800 million to ACM's total available market opportunity. While these are semi-critical cleaning steps, this tool are features the same high-quality that our customers expected from us. We are off to a great start with these tools. We have already delivered a number of these tools as demo tool to current customers with some already recognized for revenue and some still in qualification. Next, turn to Slide 6. For another major announcement, the Ultra Furnace. This broad platform is our entry into dry processing application. This opens another large market for ACM beyond wet processing. In our view, innovation in a vertical furnace technology still required for industry with progress to more advanced manufactured nodes. That is why ACM into the market. We have been hard at work for furnace for more than two years. In a joint development project of our world-class technology teams in China and Korea. The two teams developed a new hardware platform that combine our premium proven software and the proprietary control system. The Ultra Furnace delivers reliable control of pressure, gas blow rate and the temperature. The Ultra Furnace is optimized to deliver high-performance batch processing of up to 100 12-inch wafers that initially supports low-pressure chemical vapor separation process or called LPCVD. With additional development work, the furnace tool can be expanded to address oxidation, annealing process and the for atomic layer deposition process. We delivered our first Ultra Furnace demo tool to a key customer in the first quarter and expect the qualification by the end of this year. Please turn to Slide 7. This represents ACM's view of the market opportunity addressed by full product line. You are all familiar with our core single-wafer wet cleaning product, SAPS, TEBO and Tahoe. We estimate this product represents a $1.5 billion market opportunity for ACM. We estimate our four recent announced products. The ECP, the SFP Stress Free Polishing and Semi-Critical Cleaning and vertical furnace products, extending our reach by another approximately $3.5 billion take us to up to $5 billion in total market opportunity. ACM commits to gaining market share through innovation and new products. We have a multiyear product roadmap, and we are committed to further developing our technology across current and new product line to address technical challenges faced by our customers at more advanced nodes in the future. Turn to Slide 8. We are confident in the opportunity to expanding beyond our current base of five major customers. We believe every major semiconductor manufacturers can benefit from our technologies. We began to broaden our sales team last year with the addition of new sales managers in the U.S. and Singapore. In early April, we announced the appointment of Jim Straus as vice president of sales for North America. Jim brings to ACM near 30 years of sales and business development experience in semiconductor capital equipment. He has a track record of success sell into top five global IC manufacturers. We're excited to have Jim on board. He will lead our effort to expanding adoption of our core technology at a major IC manufacturers in North America. Now an update on two major strategic efforts for 2020. Please turn to Slide 9. First, our land agreement. In December, we announced an agreement to acquire land right in the Lingang Region of Shanghai, 30 mile from ACM headquarters Shanghai. This will be the future site of our fully owned R&D and production facility. Negotiations are in the final stage. We expect to reach agreement very soon. If an agreement is reached, we would expect to start the construction late this year with goal to begin initial production in later 2022. Second, we are making steady progress on the Shanghai STAR Market listing. We are on track to submit ACM Shanghai's IPO application in middle 2020. We are hopeful for a timely review by the Shanghai Stock Exchange, SSE, and registration by the China Security Regulatory Commission, CSRC. If all goes wells, we will be pricing the transaction by end of the year. We are confident that the IPO will raise ACM profile in Asia and improve ACM spending with the local customer and the supply chain. The STAR Market IPO would also inject sizable capital into our China and global operation, and what we believe will be favorable valuation. This will help take ACM to the next level, enable us to accelerate our long-term business plan at a critical stage in our development. Before I turn it over to Mark, I would like to update you the COVID-19 situation and discuss our 2020 outlook. I'm happy to report that all of our staff are back to work at both of the Shanghai facility, as shown on Slide 10 and at our Korean R&D center. The Shanghai regime has stabilized further since our last call with no new local COVID-19 cases. All our production lines have returned to 100% staffing. We are working closely with our supply chain to ensure timely delivers. Most important, we are working hard to expand our capacity to handle additional loading for the rest of the year. Since outbreak, we have been in constant contact with our customers, in particular, YMTC is the first factory and its center of operations are in Wuhan. They are fully committed to scaling production. We happily report that Wuhan has officially opened and we are on track for delivery to YMTC in the second quarter and beyond. Our other customers in less affect city have also returned to work in an ordinary fashion. Operations appear to have returned to normal. Please now turn to Slide 11. As we look ahead, we remain optimistic. Let me share our current outlook, which is unchanged from last quarter. Q1 revenue and shipments expected were impacted by the COVID-19 pandemic where part of our business shift from Q1 Q2. Our internal forecast for repeat orders and first tool remain largely unchanged for the full year. Our visibility is supported by firm orders, customer forecast, and tool awaiting acceptance. Accordingly, we reaffirmed our full-year 2020 outlook. We expect revenue to be in the range of $130 million to $150 million. This will represent 30% annual growth at the mid-point. Our outlook is based on a couple of key assumptions. First, COVID-19 situation further improves in China and stabilizes in the rest of the world. Second, the low end of revenue range, assuming muted DRAM recovery, and limited revenue contribution from new customers. To conclude, I would like to thank our customers, partners, and shareholders for their continued support and confidence in ACM Research. I also want to thank our employees for their hard work and their dedication in this challenging time. We are executing on our strategy. We are investing in R&D to enhance current products and to develop new products. We are building our global sales and marketing resource to penetrate new customers in new regions, and we are scaling production capacity to support our long-term growth plan. I will now turn the call over to Mark, who will discuss financial results in more detail.